Clinical Trial Update: Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma [NA]

View source ↗

Summary

This clinical trial update describes a study of the NaviFUS System combined with bevacizumab for recurrent glioblastoma, focusing on safety and effectiveness, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• NaviFUS System

Snippet

Sponsor: University of Cincinnati | Conditions: GBM | NA | Status: NOT_YET_RECRUITING